Abstract:Our understanding of infection biology is based on experiments in which pathogen or host proteins are perturbed by small compound inhibitors, mutation, or depletion. This approach has been remarkably successful, as, for example, demonstrated by the independent identification of the endosomal membrane protein Niemann-Pick C1 as an essential factor for Ebola virus infection in both small compound and insertional mutagenesis screens (Côté, Nature 477:344-348, 2011; Carette et al., Nature 477:340-343, 2011). However, many aspects of host-pathogen interactions are poorly understood because we cannot target all of the involved molecules with small molecules, or because we cannot deplete essential proteins. Single domain antibody fragments expressed in the cytosol or other organelles constitute a versatile alternative to perturb the function of any given protein by masking protein-protein interaction interfaces, by stabilizing distinct conformations, or by directly interfering with enzymatic activities. The variable domains of heavy chain-only antibodies (VHHs) from camelid species can be cloned from blood samples of animals immunized with the desired target molecules. We can thus exploit the ability of the camelid immune system to generate affinity-matured single domain antibody fragments to obtain highly specific tools. Interesting VHH candidates are typically identified based on their affinity toward immobilized antigens using techniques such as phage display.The phenotypical screening approach described here allows the direct identification of VHHs that prevent infection of cells with influenza A virus (IAV) or other pathogens. The VHH repertoire is cloned into a lentiviral vector, which is used to generate pseudo-typed lentivirus particles. Target cells are transduced with the lentivirus, so that every cell inducibly expresses a different VHH. This cell collection is then challenged with a lethal dose of virus. Only the cells which express a VHH that prevents infection by targeting virus proteins or host cell components essential for infection will survive. We can thus identify critical target molecules including vulnerable epitopes and conformations, render target molecules accessible to informative perturbation studies, and stabilize intermediates of virus entry for detailed analysis.

Discovery of Mammalian Genes That Participate in Virus Infection.

Mutations in the IGF-II pathway that confer resistance to lytic reovirus infection

A Role for H/ACA and C/D Small Nucleolar RNAs in Viral Replication.

Resisting viral infection: the gene by gene approach.

Cellular Genetics Of Host Susceptibility And Resistance To Virus Infection

Identification of Cellular Proteins Required for Replication of Human Immunodeficiency Virus Type 1

Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis

Proteasome activity is required for reovirus entry into cells

Genetic analysis of resistance to viral infection

Attachment and Cell Entry of Mammalian Orthoreovirus

Cellular receptors for mammalian viruses

A Systemic Receptor Network Triggered by Human cytomegalovirus Entry

GateView: A Multi-Omics Platform for Gene Feature Analysis of Virus Receptors within Human Normal Tissues and Tumors

Genetics of Innate Immunity

Phenotypic Lentivirus Screens to Identify Antiviral Single Domain Antibodies

Genetic dissection of innate immunity to infection: the mouse cytomegalovirus model.

Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene

Complete in vitro assembly of the reovirus outer capsid produces highly infectious particles suitable for genetic studies of the receptor-binding protein.

Cell Recognition and Entry by Rhino- and Enteroviruses.

Efficient and accurate detection of viral sequences at single-cell resolution reveals putative novel viruses perturbing host gene expression

A virally encoded high-resolution screen of cytomegalovirus dependencies